Hou B - Search Results

1

Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer.

Song R, Li T, Ye J, Sun F, Hou B, Saeed M, Gao J, Wang Y, Zhu Q, Xu Z, Yu H. Song R, et al. Among authors: hou b. Adv Mater. 2021 Aug;33(31):e2101155. doi: 10.1002/adma.202101155. Epub 2021 Jun 25. Adv Mater. 2021. PMID: 34170581

2

Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment.

Feng B, Zhou F, Hou B, Wang D, Wang T, Fu Y, Ma Y, Yu H, Li Y. Feng B, et al. Among authors: hou b. Adv Mater. 2018 Sep;30(38):e1803001. doi: 10.1002/adma.201803001. Epub 2018 Jul 31. Adv Mater. 2018. PMID: 30063262

3

Bioinspired Multivalent Peptide Nanotubes for Sialic Acid Targeting and Imaging-Guided Treatment of Metastatic Melanoma.

Lei L, Xu Z, Hu X, Lai Y, Xu J, Hou B, Wang Y, Yu H, Tian Y, Zhang W. Lei L, et al. Among authors: hou b. Small. 2019 May;15(22):e1900157. doi: 10.1002/smll.201900157. Epub 2019 Apr 24. Small. 2019. PMID: 31018037

4

Engineering nanoparticles to locally activate T cells in the tumor microenvironment.

Wang D, Wang T, Yu H, Feng B, Zhou L, Zhou F, Hou B, Zhang H, Luo M, Li Y. Wang D, et al. Among authors: hou b. Sci Immunol. 2019 Jul 12;4(37):eaau6584. doi: 10.1126/sciimmunol.aau6584. Sci Immunol. 2019. PMID: 31300478

5

Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy.

Feng B, Hou B, Xu Z, Saeed M, Yu H, Li Y. Feng B, et al. Among authors: hou b. Adv Mater. 2019 Oct;31(40):e1902960. doi: 10.1002/adma.201902960. Epub 2019 Aug 18. Adv Mater. 2019. PMID: 31423683

6

Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer.

Gao A, Chen B, Gao J, Zhou F, Saeed M, Hou B, Li Y, Yu H. Gao A, et al. Among authors: hou b. Nano Lett. 2020 Jan 8;20(1):353-362. doi: 10.1021/acs.nanolett.9b04012. Epub 2019 Dec 3. Nano Lett. 2020. PMID: 31793787

7

Engineering Stimuli-Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy.

Hou B, Zhou L, Wang H, Saeed M, Wang D, Xu Z, Li Y, Yu H. Hou B, et al. Adv Mater. 2020 Mar;32(12):e1907210. doi: 10.1002/adma.201907210. Epub 2020 Feb 12. Adv Mater. 2020. PMID: 32048361

8

Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer.

Hu X, Hou B, Xu Z, Saeed M, Sun F, Gao Z, Lai Y, Zhu T, Zhang F, Zhang W, Yu H. Hu X, et al. Among authors: hou b. Adv Sci (Weinh). 2020 Feb 25;7(8):1903332. doi: 10.1002/advs.201903332. eCollection 2020 Apr. Adv Sci (Weinh). 2020. PMID: 32328426 Free PMC article.

9

Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer.

Zhou L, Hou B, Wang D, Sun F, Song R, Shao Q, Wang H, Yu H, Li Y. Zhou L, et al. Among authors: hou b. Nano Lett. 2020 Jun 10;20(6):4393-4402. doi: 10.1021/acs.nanolett.0c01140. Epub 2020 May 29. Nano Lett. 2020. PMID: 32459969

10

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy.

Ye J, Hou B, Chen F, Zhang S, Xiong M, Li T, Xu Y, Xu Z, Yu H. Ye J, et al. Among authors: hou b. Acta Pharm Sin B. 2022 Jun;12(6):2695-2709. doi: 10.1016/j.apsb.2021.09.021. Epub 2021 Sep 25. Acta Pharm Sin B. 2022. PMID: 35755274 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,951 results

Search Page

Filters